Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study
| Autor: | Aggarwal, Neil R., Beaty, Laurel E., Bennett, Tellen D., Fish, Lindsey E., Jacobs, Jason R., Mayer, David A., Molina, Kyle C., Peers, Jennifer L., Richardson, Douglas B., Russell, Seth, Varela, Alejandro, Webb, Brandon J., Wynia, Matthew K., Xiao, Mengli, Carlson, Nichole E., Ginde, Adit A. |
|---|---|
| Zdroj: | In The Lancet Regional Health - Americas March 2024 31 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|